| Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes I Caruana, B Savoldo, V Hoyos, G Weber, H Liu, ES Kim, MM Ittmann, ... Nature medicine 21 (5), 524-529, 2015 | 703 | 2015 |
| Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma ES Kim, A Serur, J Huang, CA Manley, KW McCrudden, JS Frischer, ... Proceedings of the National Academy of Sciences 99 (17), 11399-11404, 2002 | 438 | 2002 |
| USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis YH Fan, J Cheng, SA Vasudevan, J Dou, H Zhang, RH Patel, IT Ma, ... Cell death & disease 4 (10), e867-e867, 2013 | 197 | 2013 |
| Incidence of infertility and pregnancy complications in US female surgeons EL Rangel, M Castillo-Angeles, SR Easter, RB Atkinson, A Gosain, YY Hu, ... JAMA surgery 156 (10), 905-915, 2021 | 181 | 2021 |
| IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity D Liu, L Song, J Wei, AN Courtney, X Gao, E Marinova, L Guo, A Heczey, ... The Journal of clinical investigation 122 (6), 2221-2233, 2012 | 150 | 2012 |
| Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis J Huang, SZ Soffer, ES Kim, KW McCrudden, J Huang, T New, CA Manley, ... Molecular Cancer Research 2 (1), 36-42, 2004 | 137 | 2004 |
| Guidelines for opioid prescribing in children and adolescents after surgery: an expert panel opinion LI Kelley-Quon, MG Kirkpatrick, RL Ricca, R Baird, CM Harbaugh, ... JAMA surgery 156 (1), 76-90, 2021 | 117 | 2021 |
| A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways J Cheng, YH Fan, X Xu, H Zhang, J Dou, Y Tang, X Zhong, Y Rojas, Y Yu, ... Cell death & disease 5 (2), e1079-e1079, 2014 | 116 | 2014 |
| TGFβR1 blockade with galunisertib (LY2157299) enhances anti-neuroblastoma activity of the anti-GD2 antibody dinutuximab (ch14. 18) with natural killer cells HC Tran, Z Wan, MA Sheard, J Sun, JR Jackson, J Malvar, Y Xu, L Wang, ... Clinical Cancer Research 23 (3), 804-813, 2017 | 114 | 2017 |
| G-CSF promotes neuroblastoma tumorigenicity and metastasis via STAT3-dependent cancer stem cell activation S Agarwal, A Lakoma, Z Chen, J Hicks, LS Metelitsa, ES Kim, JM Shohet Cancer research 75 (12), 2566-2579, 2015 | 94 | 2015 |
| Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors J Huang, J Moore, S Soffer, E Kim, D Rowe, CA Manley, K O'Toole, ... Journal of pediatric surgery 36 (2), 357-361, 2001 | 93 | 2001 |
| A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma JM Shohet, R Ghosh, C Coarfa, A Ludwig, AL Benham, Z Chen, ... Cancer research 71 (11), 3841-3851, 2011 | 89 | 2011 |
| Primary malignant pancreatic neoplasms in children and adolescents: a 20 year experience Y Rojas, CL Warneke, CA Dhamne, K Tsao, JG Nuchtern, KP Lally, ... Journal of pediatric surgery 47 (12), 2199-2204, 2012 | 81 | 2012 |
| A 360° evaluation of a night-float system for general surgery: A response to mandated work-hours reduction MJ Goldstein, E Kim, WD Widmann, MA Hardy Current surgery 61 (5), 445-451, 2004 | 80 | 2004 |
| Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor SZ Soffer, JT Moore, E Kim, J Huang, A Yokoi, C Manley, K O'Toole, ... Journal of pediatric surgery 36 (8), 1177-1181, 2001 | 80 | 2001 |
| The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma A Lakoma, E Barbieri, S Agarwal, J Jackson, Z Chen, Y Kim, M McVay, ... Cell death discovery 1 (1), 1-9, 2015 | 79 | 2015 |
| Minimally invasive surgical management of benign breast lesions A Lakoma, ES Kim Gland surgery 3 (2), 142, 2014 | 78 | 2014 |
| Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma DM Patterson, D Gao, DN Trahan, BA Johnson, A Ludwig, E Barbieri, ... Angiogenesis 14, 255-266, 2011 | 77 | 2011 |
| G-CSF receptor positive neuroblastoma subpopulations are enriched in chemotherapy-resistant or relapsed tumors and are highly tumorigenic DM Hsu, S Agarwal, A Benham, C Coarfa, DN Trahan, Z Chen, ... Cancer research 73 (13), 4134-4146, 2013 | 76 | 2013 |
| Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the … HJ West, M McCleland, F Cappuzzo, M Reck, TSK Mok, RM Jotte, ... Journal for Immunotherapy of Cancer 10 (2), 2022 | 75 | 2022 |
